Introduction {#S0001}
============

Successful parasites have evolved to live and develop in specific hosts during their biological cycle. They have accumulated adaptations in response to environmental changes such as the immune response of the host. The repetition of the parasite-host interaction cycle ensures the persistence of several species of parasites. In humans, this interaction causes health disorders known as vector-borne and parasitic diseases.

According to the WHO, human parasitic diseases cause more than 700,000 deaths each year (<http://www.who.int/vector-control/en/>). These infectious diseases are caused by parasites from the group of protozoa and helminths. Some species of arthropods are also parasites and produce the so-called ectoparasitic diseases. Many of these diseases are classified as Neglected Tropical Diseases (NTDs) because they are caused by pathogens present in tropical and sub-tropical areas, and are often overlooked by pharmaceutical companies and even the public health community.

Trypanosomatidae is a vast family of protozoan parasites characterized by the presence of a single flagellum and a compacted DNA called kinetoplast. All members are exclusively parasitic, found primarily in insects. A few genera have life-cycles involving a secondary host, which may be a vertebrate, invertebrate or plant. These include several species that cause major diseases in humans \[[1](#CIT0001)\]. The three major human diseases caused by trypanosomatids are Leishmaniasis, caused by various species of the genus Leishmania; African trypanosomiasis (or "sleeping sickness"), caused by *Trypanosoma brucei*; and American trypanosomiasis or Chagas disease, caused by *Trypanosoma cruzi*. These digenetic parasites have complex biological cycles in response to the specific adaptations required to live within two very different types of hosts, the insect vector and the mammalian organism.

Autophagy is an intracellular catabolic pathway highly conserved in eukaryotic organisms. Experimental and genomic data showed that the autophagy machinery characterized in animals and fungi also appeared in protists and function for diverse lifestyle adaptations \[[2](#CIT0002)\]. Pathogenic protists can either utilize their own autophagy mechanisms or manipulate host-cell autophagy in order to establish or maintain infection within a host. This work revises the involvement of *T. cruzi* and host cell autophagy during the *T. cruzi* life-cycle.

The *T. cruzi* life-cycle and the infection process {#S0002}
===================================================

During its complex life cycle, *T. cruzi* is found in three different parasitic forms. Epimastigotes and amastigotes are the replicative stages found in the lumen of the intestine of triatomine insect vectors or in the cytosol of infected host cells, respectively. The infective forms of *T. cruzi* are metacyclic trypomastigotes and blood-stream trypomastigotes, derived from epimastigotes and amastigotes, respectively, both with the capacity to invade a large number of different cell types in a process independent of host cell actin polymerization \[[3](#CIT0003)\]. The so-called extracellular amastigotes, originated from the premature rupture of infected cells or transformed from swimming trypomastigotes, are also infective forms that, in contrast to trypomastigotes, require functional intact microfilaments to infect non-phagocytic host cells \[[4](#CIT0004),[5](#CIT0005)\].

The *T. cruzi* entry process was classically divided into two specific steps ([Figure 1](#F0001), points 1 and 2): the adhesion process, related to the binding of *T. cruzi* antigens to host cell receptors which trigger cell signaling events \[[6](#CIT0006),[7](#CIT0007)\]; and the internalization process that describes the mechanism that culminates in the formation of the *T. cruzi* parasitophorous vacuole (TcPV). Adhesion of trypomastigotes is driven by a repertoire of molecules present at the parasite surface or secreted during the infection process which bind to the specific receptors in the host cells \[[6](#CIT0006),[8](#CIT0008),[9](#CIT0009)\]. Despite the advances made towards identification of the receptor molecule responsible for the adhesion of parasites, no single main host receptor candidate has been identified yet. In fact, the arsenal of parasite surface proteins and the multiple possible host receptors provide several opportunities for *T. cruzi* to recognize and contact cells and explains why this parasite is able to infect almost all types of mammalian cells \[[10](#CIT0010),[11](#CIT0011)\]. The adhesion to cell surface triggers a host cell signaling cascade that culminates in the formation of the *T. cruzi* parasitophorous vacuole. Different processes have been described for the internalization of *T. cruzi* into non-phagocytic cells. Seminal studies showed two different models of trypomastigote invasion: by activating the lysosomal exocytosis or by inducing an endocytosis-like process. Both agree on the absence of plasma membrane protrusions (and microfilaments) but differ in the source of the membrane that initially envelops the parasite. The first model demonstrated that parasites elicited a Ca2+ signaling cascade in the host cells which activates lysosomal exocytosis \[[12](#CIT0012)\]. The later fusion of lysosomes with the host plasma membrane allows the parasite entry and the formation of a parasitophorous vacuole with lysosomal characteristics \[[13](#CIT0013)\]. This lysosomal exocytosis is produced with the peripheral pool of lysosomes and require microtubules and kinesin to the lysosomal transport toward the plasma membrane \[[14](#CIT0014),[15](#CIT0015)\]. Autophagy has also been shown to participate in this process by the finding of autophagic proteins in the TcPV membrane \[[16](#CIT0016)\] (see below). In contrast, the endocytosis-like process claims that at very early times after infection, the highest proportion of trypomastigotes enter host cells by invagination of the plasma membrane that generates an initial TcPV enriched in phosphoinositides derived from plasma membrane but not lysosomal markers \[[17](#CIT0017)\]. This model reinforced previously published data that demonstrated the participation of endocytic GTPases such as Rab5 and Rab7 and dynamin in the *T. cruzi* infection process \[[18](#CIT0018),[19](#CIT0019)\]. Later studies showed that *T. cruzi* exploited the plasma membrane wound repair mechanism \[[20](#CIT0020)\] carried out by the exocytosis of lysosomes at the site of the injury followed by the compensatory endocytosis of injured membranes \[[21](#CIT0021)\]. In summary, both events, exocytosis and endocytosis, previously classified as independent processes, now, under the light of these new data, have been shown to occur sequentially during parasite invasion. The different styles of *T. cruzi* entry were also associated with the different trypomastigote forms. Metacyclic trypomastigotes (MT) that express gp82, the surface molecule that mediates invasion, induce mTOR dephosphorylation and lysosome biogenesis and scattering, evidencing preferentially the lysosomal exocytosis process. In contrast, the entry of tissue culture trypomastigotes (TCT), the equivalent to blood-stream trypomastigotes, is predominantly related to endocytosis \[[22](#CIT0022)\]. Other forms of *T. cruzi* entry into host cells, such as phagocytosis and macropinocytosis, have been also described \[[23](#CIT0023)\].

In addition to the specific manner of TcPV formation, there is a third little described step during *T. cruzi* invasion that involves the TcPV maturation ([Figure 1](#F0001), point 3). Fusion of lysosomes with the early parasitophorous vacuole is crucial to the progress of infection. Previous works from the laboratory of Norma Andrews have demonstrated that when lysosomal fusion was inhibited, internalized parasites failed to be retained inside host cells and escaped to the extracellular environment \[[24](#CIT0024),[25](#CIT0025)\]. The abolition of this phenomenon, known as reversal infection, by allowing the lysosomal fusion to TcPV, is a key process for the retention of *T. cruzi* inside the host cell \[[26](#CIT0026)\]. In agreement with this, further studies from our group demonstrated that the SNARE VAMP7 and its partner Vti1b, both components of the molecular machinery that promotes lysosomal fusion, are required during *T. cruzi* vacuole development and, as a consequence, for the parasite infection \[[27](#CIT0027)\]. We have also shown that migration of VAMP7 positive vesicles to the TcPV depends on KIF5, a motor protein belonging to the superfamily of kinesins. It was suggested that the highly motile trypomastigotes contained in vacuoles fail to associate with microtubules when lysosomal fusion is impaired, allowing the parasites to continue to move around the cytosol and eventually leave the cell. In the same way, the loss of parasite motility associated with the lysosomal fusion to the TcPV could be attributed to the beginning of the differentiation process from trypomastigotes to non-motile amastigotes induced in part by the acidic pH gained by the vacuole during this process. The striking morphological transition undergone by the parasite throughout the course of the infection process, from the typical elongated form at early times to the ovoid form at later times \[[27](#CIT0027)\] strengthens this idea. Maturation of the vacuole is finally a key process for both the retention of *T. cruzi* inside the host cell and for the progression of the *T. cruzi* intracellular cycle by allowing the differentiation from trypomastigotes to amastigotes.10.1080/21505594.2018.1543517-F0001Figure 1.The three steps of the *T. cruzi* invasion. The scheme summarizes the process of *T. cruzi* entry into the host cell. (1) Adhesion of trypomastigotes to the host cell surface. (2) Internalization of trypomastigotes produced by invagination of the plasma membrane. (3) Vacuole maturation proceeds after the fusion with lysosomes which initiates the differentiation of *T. cruzi* from trypomastigotes to amastigotes.

The autophagic pathway {#S0003}
======================

Autophagy is a catabolic pathway conserved in most eukaryotes from yeast to mammalian cells \[[28](#CIT0028)\]. This process involves the cellular self-digestion through the lysosomal machinery. Macroautophagy, the most widely studied type of autophagy, is important in many physiological situations such as cell development, cell growth, and cell differentiation. As a constitutive process, autophagy functions at basal levels in the turnover of long-lived proteins and old organelles for maintaining cellular homeostasis. Nutritional stress conditions are the main physiologic stimulus of autophagy. Under these situations, cells entrap cytoplasmic materials and degrade them to provide aminoacids that function as energy source for cell survival \[[29](#CIT0029)\]. Besides this bulk degradation process, autophagy functions selectively to remove misfolded or aggregated proteins, damaged organelles, such as mitochondria, endoplasmic reticulum and peroxisomes, as well as to eliminate intracellular pathogens, being part of the innate immune response \[[30](#CIT0030)\]. The autophagic pathway involves specific compartments inside the cell. Basically, the cytoplasmic cargo is captured through the intermediary of a double membrane-bound vesicle, referred to as autophagosome, which fuses with the lysosome to form an autolysosome. In mammalian cells, autophagosomes derived from an isolation membrane, also known as phagophore, which is likely derived from a lipid bilayer contributed by the endoplasmic reticulum and/or the trans-Golgi and late endosomes \[[31](#CIT0031)--[33](#CIT0033)\]. The outer mitochondrial membrane and the plasma membrane can also participate as membrane donor \[[34](#CIT0034)\]; therefore, the exact origin of the phagophore in mammalian cells is still controversial. The isolation membrane grows around the cargo and finally closes to form the early autophagosome, easily recognized as a double-membrane vesicle by electron microscopy \[[35](#CIT0035)\]. Autophagosomes can then fuse with endocytic compartments to form amphisomes, which, in turn, fuse with lysosomes, forming autolysosomes where the proteins are degraded to amino acids that are recycled via lysosomal permeases and other transporters \[[36](#CIT0036)\].

Specific molecules coordinate this complex process. To date, different autophagy-related genes (Atg) have been identified by genetic screening in yeast \[[28](#CIT0028)\]. Many of them have been conserved in mammalian cells. These genes can be grouped according to their functions at key stages of the autophagy pathway: initiation, elongation, maturation, and fusion with the lysosomes. In mammalian systems, the phagophore is derived from membranes enriched in phosphatidyl inositol triphosphate (PI3P), the product of the Beclin1-Vps34 complex \[[37](#CIT0037)\]. Phagophore elongation requires the sequential activation of two protein conjugation reactions. The mammalian Atg5-Atg12-Atg16L complex is recruited to the isolation membrane, favoring the extension of the precursor membrane \[[38](#CIT0038)\]. LC3, the mammalian homolog of Atg8, is then conjugated with phosphatidylethanolamine (PE) to form LC3-II, which inserts into the autophagosome membrane and contributes to vesicle elongation \[[39](#CIT0039)\]. After autophagic induction LC3-II is visualized by a punctuate pattern corresponding to autophagic vesicles. Unlike the Atg5-Atg12.Atg16L complex, LC3-II remains on completed autophagosomes and also on autolysosomes \[[40](#CIT0040)\]. The final steps of autophagy involve docking and fusion of autophagosomes to lysosomes to generate autolysosomes which produce cargo degradation and recycling. Specific Rab GTPases and SNAREs proteins function as master regulators of these fusion events. Impairment of this process by the use of mutant proteins or chemicals prevents the normal maturation of the pathway leading to the accumulation of autophagosomes. Bafilomycin A1 is a broadly used autophagic flux inhibitor that prevents the fusion of autophagosomes with endosomes/lysosomes and the autophagic degradation \[[41](#CIT0041)\].

Two key signaling processes converge to correlate canonical autophagy with cell nutrient or stress conditions, the mTOR and the PI3K pathways. The mTOR signaling cascade transduces the response from growth factors, via class I PI3K, Akt/PKB, and so forth, to negatively regulate autophagy \[[42](#CIT0042)\]. Rapamycin is one of the classical inducers of autophagy due to inhibition of the mTOR signaling pathway \[[43](#CIT0043)\]. As mentioned above, Beclin1-Vps34 complex is necessary to produce the PI3P required in the phagophore formation and elongation. This class III PI3K complex is inhibited by wortmannin, which blocks the autophagosome initiation process \[[44](#CIT0044)\].

The process of autophagy can be monitored intracellularly by utilizing LC3 fused to a fluorescent protein such as GFP-LC3 or mCherry-LC3. Fluorescent LC3 is incorporated into the autophagosomes and could be observed as small dots inside the cell by light microscopy. The number of puncta in a cell at any specific time is a function of both the formation and the clearance of autophagosomes \[[45](#CIT0045)\].

Selective autophagy refers to the different mechanisms of capture and degradation of specific cargos by autophagy. These non-canonical classes of autophagy are named according to the type of component that has been incorporated to the route, such as mitophagy, pexophagy and xenophagy \[[46](#CIT0046)\], among others. Xenophagy is the process by which cells can degrade an intracellular microorganism present inside a phagosome \[[47](#CIT0047),[48](#CIT0048)\] or free in the cytosol \[[49](#CIT0049)\]. Due to this property, xenophagy has been classified as a component of the innate immune responses against intracellular pathogens. Xenophagy generally functions as a second barrier when phagocytosis or other defense mechanisms are exceeded. However, some pathogens have the capacity to evade autophagic responses or to subvert the autophagic pathway and to live and replicate inside an autophagosomal compartment (see below). Recent research has related LC3 protein to pathways other than autophagy. Since 2007, the concept of LAP (LC3-associated phagocytosis) has been introduced. Nowadays LAP is understood as a type of non-canonical autophagy. LAP uses some autophagic components but it differs mainly in that the LC3 positive vesicle is a simple membrane compartment \[[50](#CIT0050),[51](#CIT0051)\].

Autophagy during the *T. cruzi* life-cycle {#S0004}
==========================================

As eukaryotic organisms, protists possess a rudimentary autophagic pathway that functions at specific stages of their life-cycles mainly during the differentiation processes \[[2](#CIT0002)\]. Autophagy is also activated when pathogenic protists are treated with anti-parasitic drugs, as a mechanism to overcome the stress caused by the toxic compounds before cell death \[[52](#CIT0052)--[55](#CIT0055)\]. In addition, a growing body of evidence shows that intracellular protists have the ability to manipulate host-cell autophagy in order to establish or maintain the infection within a host. Below we summarize the findings made on the *T. cruzi* autophagy pathway and its participation in the differentiation processes, and then we describe the recent advances concerning the interaction of *T. cruzi* with host cell autophagy.

Autophagy is induced during the *T. cruzi* differentiation processes {#S0005}
====================================================================

The first evidence for the existence of an autophagic-like process in *T. cruzi* was provided, as in mammalian cells, by morphological studies showing the presence of double-membrane vesicles and multivesicular structures in parasites treated with trypanocidal drugs \[[56](#CIT0056),[57](#CIT0057)\]. Later genome database searches supplemented with more advanced analyses revealed the presence of autophagy-associated components in *T. cruzi* \[[58](#CIT0058)--[60](#CIT0060)\]. These bioinformatics analyses showed that only half of the genes found in yeasts were present in trypanosomatids. *T. cruzi* possesses all components of the LC3/Atg8 conjugation system, but lacks the Atg5-Atg12 protein complex, indicative of a different manner to initiate and elongate the autophagosome. Two TcAtg8 homologs have been found in *T. cruzi*: TcAtg8.1 and TcAtg8.2. Only the first one was functionally linked to autophagy \[[60](#CIT0060)\]. During starvation, TcAtg8.1 is efficiently cleaved by one of the two TcAtg4 homologs (autophagins) and then, after conjugation to PE, is inserted in the membrane of the autophagosome-like vesicles \[[60](#CIT0060)\]. Further studies from our lab established the participation of autophagy during the differentiation of *T. cruzi* from epimastigotes to metacyclic trypomastigotes \[[61](#CIT0061)\]. This process, called metacyclogenesis, takes place in the lumen of the intestine of the triatomine vector. The reduced nutrient availability produced by the high multiplication of epimastigotes is the main stimulus to induce it. By performing an *in vitro* method of differentiation, we showed an increment in the number of Atg8.1 positive vesicles during starvation. The same result was observed in the presence of other autophagy inducers such as rapamycin, the classical inhibitor of TOR kinase, and spermidine, a polyamine that induces autophagy in many eukaryotic organisms by regulation of gene expression and protein activity \[[62](#CIT0062)\]. We also showed that classical autophagy inhibitors such as wortmannin impaired the autophagosome formation in *T. cruzi* \[[61](#CIT0061)\]. In agreement with this, Schoijet et al. \[[63](#CIT0063)\] showed that TcVps34 kinase (the parasitic counterpart of the mammalian Beclin-1-Vps34 kinase) is regulated by TcVps15 and that both form a complex that participates in starvation induced autophagy in *T. cruzi*. As mentioned above, bafilomycin is a H^+^ pump inhibitor that impairs the normal autophagic flux, producing an accumulation of autophagic structures \[[41](#CIT0041)\]. In contrast to mammalian cells, in *T. cruzi* bafilomycin inhibits the first steps of autophagy, evidenced by the low number of Atg8.1 positive vesicles generated under this treatment. A previous work showed that formation of autophagosome in the related parasite *T. brucei* requires the normal acidification of acidocalcisomes, acidic parasitic compartments required for osmoregulation \[[64](#CIT0064)\]. Acidification impairment of acidocalcisomes by bafilomycin treatment completely abrogates autophagic response, indicating that these compartments could be participating in the first steps of autophagy in trypanosomes in a not yet clearly understood mechanism.

Autophagy is also required during the differentiation of trypomastigotes to amastigotes, a process that starts in the acidic environment of the parasitophorous vacuole and finish in the host cell cytosol. Our previous data showed that starvation in PBS and rapamycin were able to induce this process similarly to low pH. Moreover, we observed Atg8-decorated vesicles in amastigotes present in the cytosol of infected cells, indicating that autophagy can be induced in the parasite inside the host \[[16](#CIT0016)\]. Although more studies will be necessary in the future to elucidate the specific mechanisms that regulate autophagy in trypanosomatids, these data show that this process is an interesting target to be modulated to impair *T. cruzi* survival in the host.

Host autophagy during *T. cruzi* infection {#S0006}
==========================================

Invasion of trypomastigotes {#S0006-S2001}
---------------------------

As mentioned above, the interaction between host autophagy and intracellular pathogens has different fates according to the type of microorganism and host cell. Many microorganisms can be engulfed by autophagic compartments and eliminated in an autolysosome by xenophagy. Another group of pathogens has the ability to subvert the autophagic pathway to its own benefit. Some pathogens inhibit the autophagic flux to replicate in an autophagic niche which does not fuse with lysosomes \[[65](#CIT0065)\]. Others have evolved to live and replicate inside a compartment with autolysosomal characteristics \[[66](#CIT0066)--[69](#CIT0069)\]. In the case of *T. cruzi*, our data showed that this parasite exploits autophagy to support invasionof the host cell. Previous studies from our laboratory demonstrated that parasite entry by the lysosomal route is favored under conditions that increase autophagy \[[16](#CIT0016),[70](#CIT0070)\]. Induction of autophagy before infection by starvation or other means significantly increased the percentage of infected cells by enhancing the number of lysosomal compartments (lysosomes and autolysosomes) available for *T. cruzi* infection, resulting in an increased colonization of the host cell. We also showed that the *T. cruzi* parasitophorous vacuole is decorated with LC3 protein ([Figure 2](#F0002)) and that the autophagic inhibitors wortmannin, 3-methyladenine or vinblastine suppress this recruitment and also significantly reduce the intracellular infection. Interestingly, infection was diminished in the absence of specific autophagy genes Beclin1 or Atg5, which are required for initiation of autophagy, indicating that autophagic-derived compartments are required for the increased entry of *T. cruzi* into the host cell. The pro-pathogen effects of autophagy on *T. cruzi* infection were observed in different types of host cells and of *T. cruzi* strains, demonstrating that this interaction is a widespread phenomenon \[[71](#CIT0071)\]. These data were obtained with the TCT forms of *T. cruzi*. Quite different features were described by the group of Nobuko Yoshida, working with metacyclic trypomastigotes. They showed that, in contrast to TCT, pre-starvation of cells by 2 h or rapamycin treatment reduced MT invasion whereas other conditions that promote lysosomal exocytosis increased it \[[72](#CIT0072)\]. Further data from the same group demonstrated that conditions that promote lysosome biogenesis and scattering such us 1 h starvation or treatment with sucrose, increase cell susceptibility to MT and resistance to TCT \[[22](#CIT0022)\]. Due to cellular distribution of lysosomes have different outcomes related to the treatment used (1 h or 2 h starvation or rapamycin), these data indicate that MT invasion is mainly related to lysosomal exocytosis, whereas TCT entry is predominantly an endocytosis--like process.

Concerning the mechanism of *T. cruzi* invasion, it is important to note that, as mentioned above, a growing body of evidence showed that trypomastigotes exploit the lysosome-dependent membrane repair mechanism to enter the host cell \[[21](#CIT0021)\]. In this sense, autophagy has been shown to play a role in the fixing of damaged pathogen containing vacuoles such as *Salmonella* \[[73](#CIT0073)\]. The rupture of the cell surface produced by *T. cruzi* during invasion may trigger the autophagic response as a mechanism to restore the plasma membrane integrity. In agreement with this hypothesis, our results using live imaging by confocal microscopy showed that GFP-LC3 positive vesicles move towards the plasma membrane and contact the sites where trypomastigotes bind to the membrane \[[16](#CIT0016),[71](#CIT0071)\].

A recent work showed that autophagosome formation was induced by *T. cruzi* infection. By quantifying the number of LC3 puncta in cells infected with *T. cruzi*, the authors demonstrated a gradual increment of these vesicles, which reach a maximum level at 9 h post infection \[[74](#CIT0074)\]. Unpublished data from our laboratory show that the percentage of cells with more than five LC3-positive vesicles/cell was significantly increased in cells infected with TCT of *T. cruzi* Y strain, compared to control ([Figure 2](#F0002)). Interestingly, we also observed a significantly higher number of LC3-positive tubules in these cells, which has not been observed either in the uninfected control cells or in rapamycin treated cells ([Figure 2](#F0002)). Some of these tubules are even associated with the TcPV. Previous works have associated this type of dynamic tubules with efficient pathogen proliferation \[[75](#CIT0075),[76](#CIT0076)\]. Induction of these tubules in cells infected with *T. cruzi* could favor the arrival or elimination of specific molecules into the TcPV, creating a favorable niche for the parasite. More experiments will need to confirm this hypothesis.10.1080/21505594.2018.1543517-F0002Figure 2.Autophagy is induced during *T. cruzi* infection. CHO cells overexpressing GFP-LC3 were infected with tissue culture trypomastigotes (TCT) of *T. cruzi* Y strain (MOI = 50) during 3 h. After fixation, cells were washed, mounted in mowiol and analyzed by confocal microscopy. (a) Control (non-infected) cells depicting the homogeneous distribution of GFP-LC3 in the soluble form. (b) Infected cell displaying numerous autophagic vacuoles and tubules (arrows) decorated with membrane-associated GFP-LC3. Note the recruitment of this protein in the membrane of the *T. cruzi* parasitophorous vacuole (asterisks) that were recognized by the typical form of trypomastigotes. (c) Percentage of cells containing more than 5 LC3-positive vesicles/cell and at least one tubule/cell at the indicated conditions. Rapamycin (50 ng/μl) were incubated for 2 h in control conditions. Scale bar: 5 μm. Data shown represent the mean ± SE from 3 independent experiments. \*p \< 0.05, \*\*\*p \< 0.001 (Student´s t-test).

Onisuka and colleagues \[[74](#CIT0074)\] also showed that *T. cruzi* infection inhibited the normal maturation of autophagosomes to autolysosomes (autophagic flux). Our investigation concerning this point was not conclusive. By using the GFP-RFP-LC3 tandem, we did not observe a different pattern of green and red colocalization, compared to control. Western blot experiments also yielded the same ambiguous results (data not shown). Unexpectedly, colocalization between DQ-BSA, one of the best markers of hydrolytic compartments, with the *T. cruzi* vacuole at different times after infection was lower compared to the marker of acidic compartments lysosensor (data not shown). On the other hand, many authors, including our laboratory, found the classical late endosomal/lysosomal markers, such as VAMP7, Lamp 1 and 2 and Cathepsin D, in the TcPV by indirect immunofluorescence \[[13](#CIT0013),[16](#CIT0016),[27](#CIT0027)\]. These evidences suggest that although lysosomal fusion to TcPV is produced during vacuole maturation, the final mature TcPV might not be as hydrolytic as supposed. If this is the case, lysosomal enzymes might not be fully delivered to the vacuole or remain with low activity inside de TcPV because of the sub-optimal pH. Another possibility is that lysosomal enzymes were not activated inside the TcPV by a currently unknown mechanism. This hypothesis may explain, in addition to other mechanisms, the resistance of the parasites to lysosomal degradation. More studies will be necessary to confirm this assumption.

Intracellular differentiation and replication of amastigotes {#S0006-S2002}
------------------------------------------------------------

As mentioned above, previous studies from our laboratory showed that conditions that increase autophagy favor the differentiation *in vitro* from trypomastigotes to amastigotes \[[16](#CIT0016)\]. Atg8 positive vesicles were also visualized in amastigotes developed in the host cells \[[16](#CIT0016)\]. Although more studies will need to confirm these findings, these evidences suggest the participation of autophagy in the *T. cruzi* intracellular differentiation. The following stage in the *T. cruzi* intracellular cycle, the proliferation of amastigotes, was not significantly impacted by the autophagic modulation in non-phagocytic host cells, compared to cells maintained in control conditions \[[16](#CIT0016)\]. Since *T. cruzi* has its own autophagic pathway that can be modulated by the same inducers and inhibitors of host autophagy \[[61](#CIT0061)\], other experimental approaches will be necessary to decipher the possible action of autophagy modulation on *T. cruzi* infected cells. In this context, autophagy-deficient host cell lines can be used to specifically assess the impact of host autophagy loss. In contrast, growth of amastigotes on professional phagocytes might be affected by the autophagic response of these cells as it is described in the following section.

Autophagy on *in vivo* models of infection {#S0007}
==========================================

To date there is not published data about the outcome of *T. cruzi* infection *in vivo* under autophagic modulation. The pathogen/autophagy relationship on models of murine infections, with the exception of a few cases, remains little understood. The effect of autophagy as an innate immune component is easier to understand, particularly with the use of knockout mice. Studies on *M. tuberculosis* murine infections showed that Atg5 deficient mice relative to autophagy-proficient littermates resulted in increased bacillary burden and excessive pulmonary inflammation evidencing the role of autophagy *in vivo* by suppressing both *M. tuberculosis* growth and damaging inflammation \[[77](#CIT0077)\]. Furthermore, mice deficient in either IFN-γ or IFN-γ receptors are highly susceptible to *M. tuberculosis* infection \[[78](#CIT0078)\]. It is known that IFN-γ is a key cytokine in the regulation of the immune responses \[[79](#CIT0079)\] that explains the high susceptibility of these mice to mycobacterial infection. This cytokine is also a strong inducer of autophagy in macrophages \[[80](#CIT0080)\]. Taking into account that macrophage activation is a key process to control *M. tuberculosis* infection, the absence of an appropriate autophagy/xenophagy response from macrophages might also explain the higher bacterial burden observed in these mice.

The main concerns with the *in vivo* models arise from the cases of pathogens for which *in vitro* studies have shown them to be favored by autophagy induction. No current evidence demonstrates that autophagy gene deletion in the host attenuates microbial disease in these cases. Therefore, the physiological significance of microbial utilization of autophagy for "promicrobial" effects remains to be established \[[81](#CIT0081)\]. In line with these thoughts, our group observed a more aggressive infection of *T. cruzi* in an autophagy deficient mice model compared to the wild type counterpart (Casassa et al, unpublished). We also observed higher levels of infection in peritoneal cells obtained from autophagy deficient mice than cells from control animals. This means that contrary to what was observed on *in vitro* infections, deficiency of autophagy on *in vivo* models resulted in an increased infection and parasite burden. These findings highlight the role of autophagy as a component of immune responses against *T. cruzi*. Future studies on the participation of autophagy at different levels of the immunity against *T. cruzi* will allow understanding the mechanisms that prevail in the establishment of the infection, particularly in the case of the chronic stage which is characterized by *T. cruzi* persistence, tissue damage and inflammatory response.

Concluding remarks {#S0008}
==================

As one of the main processes that regulate cell survival, differentiation or death, autophagy has a major participation in the *T. cruzi* life-cycle. Evidence shows that parasitic autophagy is required during the interconversion between epimastigotes, trypomastigotes and amastigotes. These changes confer to the parasite the capacity to adapt to the following host in their life-cycle making parasite autophagy an excellent target for trypanocidal drugs.

Host autophagy has also been described as a one of the main regulators of *T. cruzi* invasion with possible effects on the maturation of the parasitophorous vacuole. Therefore, modulation of this process could favor the infection control by the cell. Furthermore, the recruitment of LC3 to the *T. cruzi* parasitophorous vacuole constitutes an interesting finding that needs to be better characterized in the future, to understand which type of process, e.g. canonical autophagy; xenophagy or even LAP are involved.

The pivotal role of autophagy in pathogenicity and virulence demonstrated in *T. cruzi* suggests that autophagy machinery is a possible good target for anti-parasitic intervention. Further studies, especially using different classes of cells, phagocytic and non-phagocytic and alsoon *in vivo* models of infection by *T. cruzi*, will be mandatory to confirm the possible beneficial effect of autophagy modulation that might offer the perspective to interfere with the infective cycle of *T. cruzi* in the host.
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